BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9474008)

  • 1. Immobilization hypercalcemia in incomplete paraplegia: successful treatment with pamidronate.
    Kedlaya D; Brandstater ME; Lee JK
    Arch Phys Med Rehabil; 1998 Feb; 79(2):222-5. PubMed ID: 9474008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
    McIntyre HD; Cameron DP; Urquhart SM; Davies WE
    Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury.
    Massagli TL; Cardenas DD
    Arch Phys Med Rehabil; 1999 Sep; 80(9):998-1000. PubMed ID: 10488998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
    Varache N; Audran M; Clochon P; Lortholary A; Bouachour G; Alquier P; Basle MF
    Clin Rheumatol; 1991 Sep; 10(3):328-32. PubMed ID: 1790647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.
    Major P
    Oncologist; 2002; 7(6):481-91. PubMed ID: 12490736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the medical treatment of hypercalcemia of malignancy.
    Hall TG; Schaiff RA
    Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for treatment of childhood hypercalcemia.
    Lteif AN; Zimmerman D
    Pediatrics; 1998 Oct; 102(4 Pt 1):990-3. PubMed ID: 9755274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
    Kutluk MT; Hazar V; Akyüz C; Varan A; Büyükpamukçu M
    J Pediatr; 1997 May; 130(5):828-31. PubMed ID: 9152297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer agents for the treatment of malignant hypercalcemia.
    Kinirons MT
    Am J Med Sci; 1993 Jun; 305(6):403-6. PubMed ID: 8506902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pamidronate in the treatment of tumor-associated hypercalcemia].
    Pecherstorfer M; Janisch S; Marosi C; Wogritsch C; Bosse C; Schratzberger W; Gerber E; Fortelny A; Lenzhofer R; Rainer H
    Klin Wochenschr; 1991 Oct; 69(15):690-5. PubMed ID: 1795492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
    Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R
    J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of pamidronate in three children with renal disease.
    Sellers E; Sharma A; Rodd C
    Pediatr Nephrol; 1998 Nov; 12(9):778-81. PubMed ID: 9874327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
    Young G; Shende A
    Med Pediatr Oncol; 1998 Feb; 30(2):117-21. PubMed ID: 9403021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
    Williams CJ; Smith RA; Ball RJ; Wilkinson H
    Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.